Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application 62/738,333, filed Sep 28, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,925,832 | Compositions and Methods for Treatment of Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence UsedRemaining | Karuna Therapeutics, Inc. | In force | High confidence | ||
| US 10,933,020 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation In force · High confidence | Karuna Therapeutics, Inc. | In force | High confidence | ||
| US 11,452,692 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation In force · Low confidence | Karuna Therapeutics, Inc. | In force | Low confidence | ||
| US 11,471,413 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation In force · Low confidence | Karuna Therapeutics, Inc. | In force | Low confidence | ||
| US 11,890,378 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation In force · Low confidence | Karuna Therapeutics, Inc. | In force | Low confidence | ||
| US 12,558,317 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation In force · Medium confidence | Karuna Therapeutics, Inc. | In force | Medium confidence | ||
| Application 17/167,714 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Abandoned Abandoned Dec 3, 2022 | Karuna Therapeutics, Inc. | Abandoned | Abandoned Dec 3, 2022 | ||
| Application 19/340,263 | Compositions and Methods for Treating Disorders Ameliorated by Muscarinic Receptor Activation Pending Not granted | Karuna Therapeutics, Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Karuna Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.